Printable Copy |
The risk of type 2 oral polio vaccine use in post-cessation outbreak response.
McCarthy KA, Chabot-Couture G, Famulare M, Lyons HM, Mercer LD.
BMC Med. 2017 Oct 4;15(1):175. doi: 10.1186/s12916-017-0937-y.
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0937-y